Teva Pharmaceutical Industries : FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Elstein Amir

FORM 4	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Check this box if no	Washington, D.C. 20549
longer subject to
Section 16. Form 4 or

Form 5 obligations may STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
continue. See	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the
Instruction 1(b).

Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden hours
per response...	0.5

1. Name and Address of Reporting Person	2. Issuer Name and Ticker or Trading Symbol	5. Relationship of Reporting Person(s) to Issuer
Elstein	Amir		Teva Pharmaceutical Industries Ltd. [TEVA]			(Check all applicable)
				X	Director	____	10% Owner
(Last)	(First)	(Middle)
3. Date of Earliest Transaction (Month/Day/Year)	____	Officer (give title below)____	Other (specify below)
C/O Teva Pharmaceutical Industries Ltd.	06/15/2023
124 Dvora HaNevi'a St.,
(Street)			4. If Amendment, Date Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line)
Tel Aviv	L3	6944020		XForm filed by One Reporting Person
				____	Form filed by More than One Reporting Person
(City)	(State)	(Zip)	Rule 10b5-1(c) Transaction Indication
			Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is
			intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)

2. Transaction	2A. Deemed	3. Transaction	4. Securities Acquired
Date	Execution Date, if	Code		(A) or Disposed of (D)
(Month/Day/Year)	any	(Instr. 8)		(Instr. 3, 4 and 5)
	(Month/Day/Year)
				(A) or
		Code	V	Amount	(D)	Price

5. Amount of Securities Beneficially Owned Following Reported Transaction(s)

(Instr. 3 and 4)

6. 7. Nature of

Ownership Indirect

Form: Beneficial

Direct (D)	Ownership
or Indirect	(Instr. 4)
(I)
(Instr. 4)

Page 1 of 2.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of

2.

3. Transaction

3A. Deemed

4.

5. Number of

6. Date Exercisable and

7. Title and Amount

8. Price of

9. Number of

10.

11. Nature

Derivative

Conversion

Date

Execution Date, if

Transaction

Derivative

Expiration Date

of Underlying

Derivative

Derivative

Ownership

of Indirect

Security

or Exercise

(Month/Day/Year)

any

Code

Securities

(Month/Day/Year)

Securities

Security

Securities

Form of

Beneficial

(Instr. 3)

Price of

(Month/Day/Year)

(Instr. 8)

Acquired (A)

(Instr. 3 and 4)

(Instr. 5)

Beneficially

Derivative

Ownership

Derivative

or Disposed

Owned

Security:

(Instr. 4)

Security

of (D)

Following

Direct (D)

(Instr. 3, 4,

Reported

or Indirect

and 5)

Transaction(s)

(I)

(Instr. 4)

(Instr. 4)

Amount

or

Number

Date

Expiration

of

Code

V

(A)

(D)

Exercisable

Date

Title

Shares

Restricted

(1)

(2)

(2)

Ordinary

$ 0

Share

06/15/2023

A

21,108

Shares

21,108

21,108

D

Units

(3)

Explanation of Responses:

1. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
2. Restricted share units were granted on June 15, 2023 and vest on June 15, 2024.
3. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

/s/ Dov Bergwerk as attorney-in-fact for Amir Elstein	06/20/2023
**Signature of Reporting Person		Date

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

• Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
  Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Page 2 of 2.